Page 42 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 42

30    Assurance of sterility for sensitive combination products and materials


             A relationship between the product configuration and microorganisms
          presented to the sterilization process helps define the approach for valida-
          tion. In all sterilization modalities, product test of sterility is conducted at
          conditions less than the routine sterilization process to establish characteris-
          tics such as the D-value. The validation of the terminal sterilization process
          utilizes this information to include safety factors to extrapolate to the de-
          sired SAL. The test of sterility, performed as part of development, validation,
          or requalification, should not be confused with the test for sterility. The
          test for sterility examines microbial growth following routine processing
          (aseptic or sterilization). A test for sterility cannot, inherently, extrapolate
          to an SAL as the test for sterility can only indicate a sterile or non-sterile
          article [26].
             There are three approaches to validate the terminal sterilization process:
          1.  Bioburden-based approach,
          2.  Bioburden and BI-based approach, and
          3.  Biological indicator approach (overkill)

          3.2.3.1  Bioburden-based approach
          The  bioburden-based  approach to  terminal  sterilization  validation fo-
          cuses on the normal microbial flora on the product and can lead to the
          development of terminal sterilization processes more gentle or appropri-
          ate for combination products. All validation methodologies for radiation
          sterilization—Methods 1, 2A, 2B, and VD max    SD —are based on the biobur-
          den approach. The bioburden-based approach may also be used for gas and
          heat sterilization processes (ISO 11137-2:2012, ISO 11135-1: 2014, ISO
          14937:2009, and ISO 17665-1:2006).
             The bioburden-based approach is executed using unsterilized product
          samples that have been manufactured in accordance with routine produc-
          tion—this allows for challenging the microbial flora resulting from the pro-
          cess and materials, as opposed to samples prepared in a manner different from
          the routine manufacturing process. The product samples are typically ex-
          posed to subprocess conditions of the terminal sterilization process. In radi-
          ation, samples are processed at a low verification dose or at increasing doses,
          with samples from each tested for sterility. In EO and other gas-based pro-
          cesses, samples could be processed at different exposure times, maintaining
          constant humidity and gas concentration, or concentrations can be varied
          keeping all other variables constant, or some other combination of variation.
          For moist heat, since time is most easily and precisely controlled, the product
          is exposed at full temperature for different times while  maintaining the other
   37   38   39   40   41   42   43   44   45   46   47